Ligand · A1ADG

A1ADG · 2-methyl-3-(2-methylphenyl)quinazolin-4(3H)-one

A1ADG, 2-methyl-3-(2-methylphenyl)quinazolin-4(3H)-one (C16 H14 N2 O, 250.3 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and…

Component: A1ADG
Formula: C16 H14 N2 O
Class: ligand
Structures: 1
PDB entries: 1

Binding sites

A1ADG in 1 structure; the first of them:

8VQY · Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus methaqualone · A1ADG A402 · binds THR262, ASN265, ASP282, LEU285, MET286, PHE289, ILE228, GLN229 and 5 more

Residues it binds most

THR 3, LEU 2, MET 2, ASN 3, GLN 3, PHE 3, TYR 1, ASP 2, ILE 2, PRO 2 (residue and the binding sites it lines).

Found with

ABU · Gamma-amino-butanoic acid
PTY · Phosphatidylethanolamine
Q3G · O-[(R)-[(2S)-2-(hexadecanoyloxy)-3-(octadecanoyloxy) propoxy](hydroxy)phosphoryl]-D-serine
BMA · beta-D-mannopyranose
MAN · alpha-D-mannopyranose
NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.